Cleared Special

K032162 - ACCESS IMMUNOASSAY SYSTEM TOXO IGG ASSAY (FDA 510(k) Clearance)

Aug 2003
Decision
24d
Days
Class 2
Risk

K032162 is an FDA 510(k) clearance for the ACCESS IMMUNOASSAY SYSTEM TOXO IGG ASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II - Special Controls, product code LGD).

Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on August 8, 2003, 24 days after receiving the submission on July 15, 2003.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3780.

Submission Details

510(k) Number K032162 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2003
Decision Date August 08, 2003
Days to Decision 24 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3780